Vardenafil Improves Sexual Function and Treatment Satisfaction in Couples Affected by Erectile Dysfunction (ED): A Randomized, Double-Blind, Placebo-Controlled Trial in PDE5 Inhibitor-Naïve Men with ED and Their Partners
Authors:
- 1 November 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 3 (6) , 1028-1036
Abstract
Erectile dysfunction (ED) is a common condition with diverse sequelae affecting men and their women partners. The FINDER study aimed to evaluate the efficacy and tolerability of the phosphodiesterase type‐5 (PDE5) inhibitor, vardenafil, in a broad population of PDE5‐naïve men with ED of different etiologies and severity and included their partners’ assessments of treatment with vardenafil. Men with ED (N = 260) were randomized to receive either vardenafil or placebo in a multicenter, flexible‐dose study. Primary efficacy variables were patients’ responses to the Global Assessment Question (GAQ), and Sexual Encounter Profile questions 2 and 3 (SEP2 and SEP3). Compared with placebo, vardenafil significantly improved rates of successful “Yes” responses to SEP3 (“Did your erection last long enough for you to have successful intercourse?”) (49% placebo vs. 78% vardenafil at last period carried forward [LPCF]; P < 0.0001), SEP2 (“Were you able to insert your penis into your partner’s vagina?”) (65% placebo vs. 85% vardenafil at LPCF; P < 0.0001), and GAQ (36% placebo vs. 83% vardenafil at last observation carried forward; P < 0.0001). In addition, patients’ and their partners’ Treatment Satisfaction Scale (TSS) scores were statistically significantly improved across each of the TSS domains (satisfaction with orgasm, ease with erection, confidence, pleasure, erectile function satisfaction, and satisfaction with medication) in the vardenafil group compared with the placebo group. Vardenafil improved sexual function to the extent that both patients and their partners expressed a considerable and agreed level of satisfaction with treatment. Edwards D, Hackett G, Collins O, and Curram J. Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): A randomized, double‐blind, placebo‐controlled trial in PDE5 inhibitor‐naïve men with ED and their partners. J Sex Med 2006;3:1028–1036.Keywords
This publication has 21 references indexed in Scilit:
- Women's Sexual Function Improves When Partners are Administered Vardenafil for Erectile Dysfunction: A Prospective, Randomized, Double-Blind, Placebo-Controlled TrialThe Journal of Sexual Medicine, 2005
- Sexual Experience of Female Partners of Men with Erectile Dysfunction: The Female Experience of Men’s Attitudes to Life Events and Sexuality (FEMALES) StudyThe Journal of Sexual Medicine, 2005
- The Treatment Satisfaction Scale: A Multidimensional Instrument for the Assessment of Treatment Satisfaction for Erectile Dysfunction Patients and Their PartnersEuropean Urology, 2005
- Early Conceptual and Linguistic Development of a Patient and Partner Treatment Satisfaction Scale (TSS) for Erectile DysfunctionEuropean Urology, 2004
- Vardenafil Improves Erectile Function in Men with Erectile Dysfunction Irrespective of Disease Severity and Disease ClassificationThe Journal of Sexual Medicine, 2004
- The Efficacy and Safety of Flexible-Dose Vardenafil (Levitra®) in a Broad Population of European MenEuropean Urology, 2004
- Safety and Efficacy of Vardenafil for the Treatment of Men With Erectile Dysfunction After Radical Retropubic ProstatectomyJournal of Urology, 2003
- Finding help for sexual problems after prostate cancer treatment: A phone survey of men's and women's perspectivesPsycho-Oncology, 2003
- The role of the partner in erectile dysfunction and its treatmentInternational Journal Of Impotence Research, 2002
- Erectile Dysfunction and Coronary Risk Factors: Prospective Results from the Massachusetts Male Aging StudyPreventive Medicine, 2000